TSPO and early-onset autosomal dominant Alzheimer disease: However, it is an encouraging sign that specific TSPO ligands have been investigated as potential therapies for neurological disorders such as Alzheimer’s disease [30], multiple sclerosis [31], neuropathic pain [32], peripheral nerve injury [33], and anxiety disorders [34].